Paweł Nurzyński

Hypertension as a Predictive Factor for Survival Outcomes in Patients with Metastatic Renal Cell Carcinoma Treated with Sunitinib after Progression on Cytokines

C. Szczylik, S. Szmit, K. Filipiak, 2011, Kidney and Blood Pressure Research.

Immunology of renal cell carcinoma

K. Leśniewski-Kmak, P. Nurzyński, J. Zolnierek, 2007 .

New Treatment Options in Metastatic Pancreatic Cancer

Katarzyna Sygit, A. Badowska-Kozakiewicz, A. Deptała, 2023, Cancers.

Cardiovascular Comorbidities for Prediction of Progression-Free Survival in Patients with Metastatic Renal Cell Carcinoma Treated with Sorafenib

C. Szczylik, S. Szmit, K. Filipiak, 2012, Kidney and Blood Pressure Research.

Efficacy of targeted therapy in patients with renal cell carcinoma with pre-existing or new bone metastases

C. Szczylik, S. Oborska, A. Waśko-Grabowska, 2008, Journal of Cancer Research and Clinical Oncology.

Reversible myocardial dysfunction in a young woman with metastatic renal cell carcinoma treated with sunitinib

C. Szczylik, S. Szmit, G. Opolski, 2009, Acta oncologica.

Adiuvant therapy of colorectal cancer

C. Szczylik, L. Bodnar, G. Wcisło, 2006 .